TDP-43 pathology is one of the most common proteinopathies in ALS, and studies have shown increased levels of TDP-43 protein in the CSF of ALS patients [53,58], suggesting that it has not been properly cleared, and may indeed be used as a prognostic biomarker [58]. Here, TARDBP is linked to amyotrophic lateral sclerosis.